Chromosome biomarker patent granted
Summary
The USPTO has granted patent US12584172B2 to Oxford BioDynamics PLC for a process analyzing chromosome regions and interactions relating to physical performance. The patent was granted on March 24, 2026, with a filing date of October 21, 2019.
What changed
The United States Patent and Trademark Office (USPTO) has granted patent US12584172B2 to Oxford BioDynamics PLC. This patent covers a process for analyzing chromosome regions and interactions relevant to physical performance. The grant date is March 24, 2026, and the application was filed on October 21, 2019.
This patent grant represents a new intellectual property asset for Oxford BioDynamics PLC. While not a regulatory rule or enforcement action, it signifies innovation in the health informatics sector. Companies operating in health informatics, particularly those involved in genetic analysis or performance-related diagnostics, should be aware of this granted patent as it may impact their own research and development activities or intellectual property landscape.
Source document (simplified)
Chromosome biomarker
Grant US12584172B2 Kind: B2 Mar 24, 2026
Assignee
Oxford BioDynamics PLC
Inventors
Ewan Hunter, Aroul Ramadass, Alexandre Akoulitchev
Abstract
A process for analysing chromosome regions and interactions relating to physical performance.
CPC Classifications
C12Q 1/6876 G16H 20/30
Filing Date
2019-10-21
Application No.
17287092
Claims
6
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Grants - Health Informatics (G16H) publishes new changes.